SCHEMBL29073307

SCHEMBL29073307

CC(NC(=O)C1CC(O)CN1C(=O)C(n1cc(C2CC2)nn1)C(C)(C)C)c1ccc(-c2ccccc2)c(F)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VHL P40337 16/20 0.66
ELOC Q15369 5/20 0.48
ELOB Q15370 5/20 0.48
DPP4 P27487 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
PTGS1 P23219 3/20 0.36
MEN1 O00255 2/20 0.36
PTGS2 P35354 2/20 0.36
KMT2A Q03164 2/20 0.36
FABP2 P12104 1/20 0.36
TSHR P16473 1/20 0.36
AKR1C4 P17516 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2C P28335 1/20 0.36
DRD3 P35462 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29073319 0.92 VHL (0.66) VHLELOCELOB
SCHEMBL30570906 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL24438218 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL26909817 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL24438430 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL24438222 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL30570894 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL30570898 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL26909876 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7
SCHEMBL26909821 0.91 VHL (0.72) VHLELOCELOBDPP4DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116783183-A 1- (2- (4-cyclopropyl-1H-1, 2, 3-triazol-1-yl) acetyl) -4-hydroxy-N- (benzyl) pyrrolidine-2-carboxamide derivatives as VHL inhibitors for the treatment of anemia and cancer 基因泰克公司 2023-09-19 CN disclosed